FOLH1 and primary cutaneous T-cell non-Hodgkin lymphoma: Theranostic radionuclides such as 68Ga-pentixafor and 177Lu-PSMA/DOTA/NOTA and humanized monoclonal antibodies like Mogamulizumab show promising results for various tumors, especially in PTCL and CTCL.